Inhibitor Therapeutics, Inc. (INTI): Shares Outstanding

Annual figures by period end, from SEC filings.

172.57M
As of 2025-12-31
173.79M
As of 2026-06-30
+0.2%
3-year compound annual growth
-14.3%
5-year compound annual growth
376.86M2012-12-31: 15.56M2013-12-31: 18.89M2014-12-31: 211.42M2015-12-31: 245.35M2016-12-31: 353.45M2017-12-31: 369.60M2018-12-31: 370.08M2019-12-31: 370.45M2020-12-31: 373.64M2021-12-31: 376.86M2022-12-31: 171.79M2023-12-31: 172.02M2024-12-31: 172.32M2025-12-31: 172.57M172.57M
2012-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-31172.57M+0.1%2026-03-26, Balance as of period end
2024-12-31172.32M+0.2%2026-03-26, Balance as of period end
2023-12-31172.02M+0.1%2025-03-28, Balance as of period end
2022-12-31171.79M-54.4%2024-03-29, Balance as of period end
2021-12-31376.86M+0.9%2023-03-31, Balance as of period end
2020-12-31373.64M+0.9%2022-03-30, Balance as of period end
2019-12-31370.45M+0.1%2021-03-26, Balance as of period end
2018-12-31370.08M+0.1%2020-03-30, Balance as of period end
2017-12-31369.60M+4.6%2019-03-07, Balance as of period end
2016-12-31353.45Mn/c2018-02-16, Balance as of period end
2015-12-31245.35M+16.1%2017-02-17, Balance as of period end
2014-12-31211.42Mn/m2016-02-01, Balance as of period end
2013-12-3118.89M+21.4%2015-02-13, Balance as of period end
2012-12-3115.56Mn/a2014-04-15, Balance as of period end